Smith Mark Douglas bought JAZZ
August 5, 2026 · Form 4 insider transaction
Smith Mark Douglas bought 1,605 shares of Jazz Pharmaceuticals plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,605
Price
$0.00
Total value
N/A
InsiderSmith Mark Douglas
Role—
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateAugust 5, 2026
Filing dateAugust 7, 2026
Shares owned after11,285
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.